BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11868777)

  • 1. A message to Japan.
    Tanikawa K
    Oncology; 2002; 62 Suppl 1():101-2. PubMed ID: 11868777
    [No Abstract]   [Full Text] [Related]  

  • 2. Perspective: incision revision.
    Schwartz M
    Nature; 2014 Dec; 516(7529):S17. PubMed ID: 25470196
    [No Abstract]   [Full Text] [Related]  

  • 3. A message to Asia.
    Suzuki H
    Oncology; 2002; 62 Suppl 1():103-4. PubMed ID: 11868778
    [No Abstract]   [Full Text] [Related]  

  • 4. Interferon: benefit beyond hepatitis therapy?
    Mallat DB; El-Serag HB
    Am J Gastroenterol; 2001 Dec; 96(12):3435-6. PubMed ID: 11774964
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of hepatocellular carcinoma.
    Kew MC
    S Afr J Surg; 2011 Apr; 49(2):50-1, 86. PubMed ID: 21614973
    [No Abstract]   [Full Text] [Related]  

  • 6. [Significance of medical examination for HCV infection as a national project for prevention of hepatocellular carcinoma in Japan].
    Katayama K; Tanaka J; Komiya Y; Kumagai J; Yoshizawa H
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):248-52. PubMed ID: 15359801
    [No Abstract]   [Full Text] [Related]  

  • 7. [Multicenter study on the inhibition of hepatocarcinogenesis by interferon therapy (IHIT)].
    Yoshida H; Omata M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):463-6. PubMed ID: 15359842
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon for decreasing the incidence of hepatocellular carcinoma in patients with chronic hepatitis C.
    Hayashi N; Kasahara A
    Oncology; 2002; 62 Suppl 1():87-93. PubMed ID: 11868793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis B and hepatitis C, a high stake for public health: how to reconcile health cost control and public health expenses?].
    Allerg Immunol (Paris); 1997 Sep; 29(7):215-8. PubMed ID: 9432191
    [No Abstract]   [Full Text] [Related]  

  • 10. Occurrence of hepatocellular carcinoma in HIV/HCV co-infected patients treated with direct-acting antivirals.
    Hasson H; Merli M; Messina E; Bhoori S; Salpietro S; Morsica G; Regalia E; Bagaglio S; Lazzarin A; Uberti-Foppa C; Mazzaferro V
    J Hepatol; 2017 Aug; 67(2):415-417. PubMed ID: 28411040
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis C: new CDC screening recommendations.
    Campos-Outcalt D
    J Fam Pract; 2012 Dec; 61(12):744-6. PubMed ID: 23313992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oncogenic hepatitis C virus and direct-acting antivirals: economic implications for hepatocellular carcinoma in Medicaid beneficiaries with cirrhosis.
    Mantravadi S
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP180-SP184. PubMed ID: 28665676
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemoprevention of hepatocellular carcinoma in hepatitis C virus-related cirrhosis: first, eliminate the virus.
    Valla DC; Degos F
    J Hepatol; 2001 Apr; 34(4):606-9. PubMed ID: 11394663
    [No Abstract]   [Full Text] [Related]  

  • 14. Addressing the Challenges of Hepatitis C Cure and Persistent Risk of Hepatocellular Carcinoma.
    Baumert TF; Hoshida Y
    Viruses; 2019 May; 11(5):. PubMed ID: 31096600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma.
    Kumada H
    Oncology; 2002; 62 Suppl 1():94-100. PubMed ID: 11868794
    [TBL] [Abstract][Full Text] [Related]  

  • 16.  Ongoing alcohol consumptions counteracts the benefits of sustained virological response in patients with well compensated hepatitis C cirrhosis: an observational study.
    Hernaez R; El-Serag H
    Ann Hepatol; 2017 Jan-Feb 2017; 16(1):16-20. PubMed ID: 28051790
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluating the efficacy of interferon therapy on hepatitis C patients].
    Shiraha H; Iwasaki Y; Shiratori Y
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):489-92. PubMed ID: 15359847
    [No Abstract]   [Full Text] [Related]  

  • 18. New horizons in hepatitis B and C in the older adult.
    Kemp L; Clare KE; Brennan PN; Dillon JF
    Age Ageing; 2019 Jan; 48(1):32-37. PubMed ID: 30379991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between hepatocellular carcinoma and hepatitis B and C virus.
    Kohli A
    Clin Adv Hematol Oncol; 2016 Feb; 14(2):96-8. PubMed ID: 27057807
    [No Abstract]   [Full Text] [Related]  

  • 20. [Steatosis and hepatitis C].
    Testino G
    Recenti Prog Med; 2005 Dec; 96(12):621-33; quiz 654. PubMed ID: 16496750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.